Cutaneous T-Cell Lymphoma, Relapsed
1 competing product in clinical development for Cutaneous T-Cell Lymphoma, Relapsed.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Mogamulizumab | Kyowa Kirin | Phase 2 | Active | 39 |
1 competing product in clinical development for Cutaneous T-Cell Lymphoma, Relapsed.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Mogamulizumab | Kyowa Kirin | Phase 2 | Active | 39 |